Nabla’s Post

Outstanding recommendations to ensure success with your AI ambient scribe pilot and implementation. The key points for me: - Ensure the tech works for the clinicians and not the other way around. - Can the vendor customize the product to your clinicians’ needs? - Nabla has become a key partner to numerous organizations thanks to their strong focus on customization, adapting the product to a wide array of workflows. - Encourage your team to provide candid and thorough feedback. This is where the magic happens, as even small changes can significantly enhance the solution and transform their entire workflow. - Work with a vendor that’s quick to implement changes and updates, and who has the capacity to support your … users during the pilot in a timely and effective way. - Will the vendor demonstrate agility and responsiveness to meet your clinicians’ needs, ensuring seamless adoption? - Is this vendor financially viable for your organization? - Does this vendor have a successful track record?

🌐 𝗝𝗼𝗶𝗻 𝗠𝗮𝘅𝗶𝘀𝗜𝗧 𝗮𝘁 𝗦𝗖𝗢𝗣𝗘 𝗨𝗦 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟰 - Redefining Clinical Trial Management with AI. The world of clinical trials is evolving at an unprecedented pace, and at MaxisIT, we're at the forefront of reshaping its future. MaxisIT doesn't just streamline trial management; it propels towards proactive responses, shaping the future of clinical trials. Discover the transformative power of our AI-powered Clinical Trials Oversight System at Booth #617 during the SCOPE US Summit 2024 from 11-14 Feb, 2024. Our platform integrates diverse data sources, providing unparalleled oversight with intelligent analytics. Click this link to book a personalized slot in advance: https://lnkd.in/edkmtkyq Zena Horaibi Ankur Goel Jameson Luks #SCOPEUS2024 #ClinicalTrials #ClinicalData #AIInHealthcare #MaxisIT #InnovationInResearch

Incredible conference of AI leaders, including our team, heads of LLMs, and multinationals! It's this week in San Francisco from Tuesday, July 9 - 11. Info + discounted tickets: bit.ly/4cyf8OA. Our team is speaking on Wednesday, July 10 at 2:20 pm on the main stage - session description: "Join Ramin Bastani CEO, Sam Warmuth, Chief Product Officer, and Gabriella Palmeri, VP of Partnerships of Healthvana, as they dive into the innovative deployment of generative AI in the healthcare sector. Recognized by the White House for their groundbreaking work, Healthvana stands as one of the largest direct-to-consumer Gen AI patient-facing applications - and there is no "human-in-the-loop." This session will explore how Healthvana effectively grounds AI-generated responses with a robust knowledge base, ensuring accuracy and reliability in a highly regulated industry. Learn best practices for implementing nimble yet responsible AI solutions that enhance patient engagement and improve health outcomes. Gain insights into the future of AI in healthcare from leaders at the forefront of this technological revolution."

Join us for another fascinating webinar! Clinical Validation for Software Integrating Artificial Intelligence - Comparison between #MedicalDevice and #InVitroDiagnostics. #ClinicalValidation of software with #AI is topic of major importance and relevance these days, for example being featured prominently during the Regulatory Affairs Professionals Society (RAPS) #EuroConvergence 2024. Link to the webinar: https://lnkd.in/dfTKfhpm #IVD #MD #RAPSEuroConvergence #ClinicalValidation #KünstlicheIntelligenz #KIValidierung #Artificialintelligence

Do more with less with DAX Copilot. By using AI to automatically turn the patient/physician conversation into documentation, you can improve clinical efficiency as well as patient and physician satisfaction. Learn more at https://lnkd.in/e86xfcb7

Real-world data provides an opportunity to understand what happens to patients, but there are limitations to the insights we can generate using traditional analysis techniques alone... In this episode of tHEORetically Speaking, Dr. Joseph Zabinksi, VP and Head of Commercial Strategy and AI at OM1, Inc., explains how AI-powered digital phenotyping can enhance our understanding of patients’ experiences and inform access, treatment and condition management: https://bit.ly/49UEUdc

Especially pertinent to health care, we build and adopt AI in our design processes, constantly identifying challenges for specific use cases, re-looking benefits through different agile iterations, striving to bring about better and tangible outcomes and what makes sense, not just for clinicians as users, but ultimately for our patients. Check out more of what Andy Ta shared at the recent World AI Show.

My colleagues, Johanna DeYoung and Karen Mindermann, will take the keynote stage at the Ai and Data in Pharma Healthcare Summit in Munich on 18 April. How do you unlock the value of data and AI? They'll discuss this and share stories of impactful industry work, including with our partner, Alteryx. Let me know if you'll be in Munich; I'd love to make an introduction!

Every day, teams are pressed to make decisions based on chaotic, disconnected flows of #biospecimen status and consent information. In our next webinar, we’ll demonstrate how #conversationalAI can enable you and your team to speak to your biospecimen #data. Ask a question, get an answer, and begin your journey from chaos to insight across the entire biospecimen lifecycle. Join Bill Hall and Messina Wiley as they showcase our #VSIM virtual Sample Inventory Management solution, powered by an AI-enabled Biomarker Intelligence Platform and Virtual Assistant. https://lnkd.in/eck_kjnw

Some reflections on the EPA Conference in Amsterdam 12-13th March 2024. Many great presentations, often concurrently! It was also great to see many familiar faces and be reminded it’s a small world as well as meet new people! Few quick points of note: • There is a lot of alignment on the challenges related to JCA across stakeholders; this was a forum where a topic shared the spotlight with AI, an impressive feat these days! • Early thinking through access challenges becoming even more important than it is already • Patient centricity and more nuanced definitions of value permeating many discussions, this is a hugely positive point • The opportunities for the use of AI to enhance working through complex issues